Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Turnaround Potential
1340.4000 4.70 (0.35%)
NSE Apr 09, 2026 15:31 PM
Volume: 938.6K
 

logo
Aurobindo Pharma Ltd.
29 May 2023
1340.40
0.35%
buy
by ICICI Direct
Target: 615
ICICI Direct
 
Geojit BNP Paribas increased Buy price target of Aurobindo Pharma Ltd. to 1502.0 on 01 Apr, 2026.
More from Aurobindo Pharma Ltd.
Recommended
Market closes lower as Middle East tensions weaken ceasefire optimism
Trendlyne Marketwatch | 09 Apr 2026, 03:57PM
After the drop, are stock market valuations finally reasonable?
The Baseline | 09 Apr 2026, 03:18PM
A deal is called off, increasing the chance for Aurobindo Pharma to be debt free
| 15 Jul 2020